Skip to main content

Table 1 Differences in etiology distribution according to smoker status

From: Tobacco and end stage renal disease: a multicenter, cross-sectional study in Argentinian Northern Patagonia

End-stage renal disease etiology

Smoker status

Total (number and %)

Current (% and 95 % CI)

Never (% and 95 % CI

Passive (% and 95 % CI

Former (% and 95 % CI

Diabetes

14 (6–21.9)

24.5 (20.6-28.3)

22 (21.7-22.4)

24 (19.7-28.5)

143 (22.5)

Glomerulonenephritis

28 (18.8-37.1)

18.2 (17.9-18.5)

13 (9–16.9)

16 (10.5-21.6)

115 (18.1)

Nephrosclerosis

19.3 (19.2-19.5)

16.1 (10.3-21.9)

27.3 (21–33.5)

19 (18.4-19.5)

122 (19.2)

Unknown

23.7 (22.7-24.6)

25.5 (19.9-31)

16.9 (12.4-21.3)

22 (19.8-23.9)

144 (22.6)

Obstructive uropathy

0

5.7 (4.9-6.5)

5.2 (4.4-5.9)

8.8 (1.5-15.9)

39 (6.1)

Others

15 (11.7-18.3)

10 (6.8-12.9)

15.6 (12.4-18.7)

10.2 (6.7-13.6)

73 (11.5)

Total (number and %)

93 (14.6)

192 (30.2)

77 (12.1)

274 (43.1)

636 (100)

  1. The change in etiology distribution achieved statistical significance (χ 2 = 82.34; p < 0.0001), with an important increase (from 16.1 % to 27.3 %) in nephrosclerosis in passive smokers (bold text)